Brief: Illumina And Labcorp Expand Collaboration To Broaden Access To Precision Oncology Testing
18/03/2026 13:18
March 18 (Reuters) - Illumina Inc ILMN.O: ILLUMINA AND LABCORP EXPAND COLLABORATION TO BROADEN ACCESS TO PRECISION ONCOLOGY TESTING ILLUMINA INC - NEW TEST DEVELOPMENT TO INCLUDE IVD TESTS FOR CGP AND WGS IN ONCOLOGY ILLUMINA INC - OFFERING TO PROVIDE PHARMACEUTICAL COMPANIES OPPORTUNITIES FOR COMPANION DIAGNOSTIC DEVELOPMENT Source text: ID:nPn7QV3v6a Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research